Synercid (quinupristin-dalfopristin) is now available for emergency use

Rhone-Poulenc Rorer's investigational antibiotic Synercid (quinupristin-dalfopristin) is now available for emergency use...for certain resistant gram positive infections.

It's being used for vancomycin-resistant enterococci (VRE)...and methicillin-resistant Staph aureus (MRSA) or Staph epidermidis in patients who can't take vancomycin. It also seems to be active against penicillin-resistant pneumococcus.

Both quinupristin and dalfopristin are in a new class of antibiotics called streptogramins. The combination has synergistic effects. (Hence the name Synercid.)

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote